30.63
+0.70
(2.34%)
May 17 - Close
NYSE
real-time data -
Disclaimer
Currency in USD
| Range | 30.02 - 30.95 |
| 52 week | 23.00 - 37.51 |
| Open | 30.02 |
| Vol / Avg. | 252,779.00/235,315.00 |
| Mkt cap | 876.73M |
| P/E | 19.59 |
| Div/yield | 0.07/0.46 |
| EPS | 1.56 |
| Shares | 28.62M |
| Beta | 0.36 |
| Inst. own | 72% |
Events
Jul 31, 2013
Q2 2013 American Vanguard Earnings Release
Jun 5, 2013
American Vanguard Annual Shareholder Meeting
- 2:00PM EDT -
May 2, 2013
Q1 2013 American Vanguard Earnings Conference Call
Apr 30, 2013
Q1 2013 American Vanguard Earnings Release
Feb 28, 2013
Q4 2012 American Vanguard Earnings Conference Call
|
More events from DailyFinance »
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 13.84% | 10.06% |
| Operating margin | 21.52% | 16.20% |
| EBITD margin | - | 19.88% |
| Return on average assets | 15.43% | 9.92% |
| Return on average equity | 29.07% | 17.89% |
| Employees | 504 | - |
| Carbon Disclosure Rating | - | - |
Address
SUITE 1250, 4695 MACARTHUR COURT
NEWPORT BEACH, CA 92660
United States - Map
+1-949-2601200 (Phone)
+1-302-6365454 (Fax)
NEWPORT BEACH, CA 92660
United States - Map
+1-949-2601200 (Phone)
+1-302-6365454 (Fax)
Website links
External links
Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Research Reports - Reuters
Discussion Group - Google Finance
Volume delayed by 15 mins.
Advertisement
Description
American Vanguard Corporation operates as a holding company. It is primarily a chemical manufacturer that develops and markets products for agricultural and commercial uses. The Company manufactures and formulates chemicals for crops, human and animal protection. It conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc. (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico S.A. de C.V. (AMVAC M), AMVAC de Costa Rica Sociedad Anonima (AMVAC CR), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC Chemical UK Ltd. (AMVAC UK), AMVAC CV (AMVAC CV), AMVAC Netherlands BV (AMVAC BV), and Envance Technologies, LLC (Envance). In July 2012, it completed the restructuring of the International Sales & Marketing function of its principal operating subsidiary, AMVAC Chemical Corporation. On November 30, 2012, AMVAC and TyraTech, Inc. formed Envance Technologies, LLC, in which the Company owns 60% interest.
Officers and directors
| Eric G. Wintemute | Chairman of the Board, Chief Executive Officer | |
| David T. Johnson | Chief Financial Officer, Vice President, Treasurer | |
| Timothy J. Donnelly | Chief Administrative Officer, General Counsel, Secretary | |
| Cindy Baker Smith | Senior Vice President & Director - Global Regulatory Affairs of AMVAC Chemical Corp | |
| Glen D. Johnson | Senior Vice President, Director - Business Development of AMVAC Chemical Corporation | |
| James R. Lehman | Vice President - Sales of AMVAC Chemical Corporation | |
| John Rizzi | Vice President, Director of Manufacturing of AMVAC Chemical Corporation | |
| Irving J. Thau | Lead Independent Director | |
| Jerome L. Coben | Director | |
| Lawrence S. Clark | Independent Director |